Stock Screener App

無料 -

インストール

1.03

5.50% -0.06

after-market

アフターアワーズ： 1.03

AEON Biopharma Inc. (AEON)

概要ニュース株価時系列ディスカッション予測

AEON Biopharma Inc. (AEON) 最新ニュース

Botox biosimilar study from AEON Biopharma set for big U.S. neurology meeting - Stock Titan

AEON PE Ratio & Valuation, Is AEON Overvalued - Intellectia AI

Growth Report: Is AEON Biopharma Inc stock good for income investorsJuly 2025 PreEarnings & AI Forecast Swing Trade Picks - baoquankhu1.vn

AEON Technical Analysis & ETF Price Forecast - Intellectia AI

Will AEON Biopharma Inc. outperform small cap indexes2025 Sector Review & Real-Time Volume Triggers - mfd.ru

AEON Biopharma (AEON) CEO awarded 3,000,000 restricted stock units - Stock Titan

AEON (AEON) files resale prospectus for up to 51.3M shares - Stock Titan

Guidance Update: Whats the profit margin of AEON Biopharma IncWeekly Market Outlook & AI Driven Price Forecasts - baoquankhu1.vn

Will AEON Biopharma Inc. stock benefit from commodity pricesJuly 2025 Sentiment & Technical Buy Zone Confirmation - mfd.ru

Short Covering: Can AEON Biopharma Inc. weather a recessionWeekly Trading Summary & Weekly Watchlist of Top Performers - baoquankhu1.vn

Profit Review: Is AEON Biopharma Inc in a long term uptrendMarket Sentiment Summary & Daily Stock Trend Reports - baoquankhu1.vn

Midday Stock Roundup: MDxHealth Up 9% Since Preliminary Q4, FY Results - Orange County Business Journal

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions - The Manila Times

AEON Biopharma completes FDA meeting, shareholders approve transactions - Investing.com

Aeon Biopharma stock falls after FDA meeting and debt restructuring By Investing.com - Investing.com Nigeria

Aeon Biopharma stock falls after FDA meeting and debt restructuring - Investing.com

Aeon Biopharma Reports bpd Type 2A Meeting With FDA And Shareholder Approval Of The November Transactions - TradingView

AEON Biopharma completes FDA meeting, shareholders approve transactions By Investing.com - Investing.com Nigeria

Shareholders back AEON debt-cut deals after FDA meeting on Botox biosimilar - Stock Titan

Growth Value: Is AEON Biopharma Inc stock good for income investorsQuarterly Trade Summary & Community Supported Trade Ideas - baoquankhu1.vn

Is EverQuote Inc. stock attractive for passive investorsWeekly Investment Summary & Long-Term Safe Return Strategies - bollywoodhelpline.com

Midday Stock Roundup: loanDepot Jumps on Trump’s Proposed Mortgage Plan - Orange County Business Journal

Rate Cut: Whats the MACD signal for AEON Biopharma Inc2025 Macro Impact & AI Powered Market Entry Ideas - baoquankhu1.vn

Do Not Use - ocbj.com

Market Wrap: Can AEON Biopharma Inc keep up with sector leadersJuly 2025 Rallies & Risk Controlled Swing Alerts - baoquankhu1.vn

AEON Biopharma (AEON) Price Target Decreased by 14.75% to 5.30 - Nasdaq

Midday Stock Roundup: Staar Down 4% on Board Changes - Orange County Business Journal

AEON Biopharma Releases Updated Investor Presentation Under Reg FD - TipRanks

AEON Biopharma, Inc. Unveils Biosimilar Strategy for ABP-450 - TradingView

AIM ImmunoTech, PepGen, Aeon, Tiziana, Moleculin: 5 Biotech Stocks That Led Retail Message Growth Last Week - MSN

Midday Stock Roundup: loanDepot Rises on Trump Move - Orange County Business Journal

AEON Biopharma (NASDAQ:AEON) & Synaptogenix (NASDAQ:TAOX) Head to Head Analysis - Defense World

Why AEON Biopharma Inc. Class stock stays on buy listsJuly 2025 Trends & Low Drawdown Investment Ideas - Улправда

Will AEON Biopharma Inc. Class stock outperform foreign stocksWeekly Stock Report & Low Drawdown Trading Strategies - Улправда

What technical signals suggest for AEON Biopharma Inc. stockGDP Growth & Momentum Based Trading Ideas - Улправда

What dividend safety rating applies to AEON Biopharma Inc. Class stockWeekly Earnings Recap & Low Risk Entry Point Guides - Улправда

AEON Biopharma, Inc. Class A Common Stock (NY: AEON - FinancialContent

What insider trading reveals about AEON Biopharma Inc. stockHigh Yield Income Stocks & Ride the Wave of Market-Beating Growth - Улправда

2026 world cup star players explained: How AEON Biopharma Inc. Class stock compares with tech leaders2026 world cup usa national team third place match key players pressing system expert forecast preview - ulpravda.ru

Will AEON Biopharma Inc. Class stock benefit from infrastructure bill2026 world cup usa national team round of 32 midfield engines transition play expert forecast tactical review - Улправда

2026 world cup match report guide: How AEON Biopharma Inc. stock benefits from global expansion2026 world cup usa national team semifinals defensive leaders pressing system winner prediction preview - Улправда

Can AEON Biopharma Inc. Class stock stage a strong rebound this quarter2026 world cup usa national team qualification playmakers high defensive line odds analysis preview - Улправда

Midday Stock Roundup: Rivian Down on Production Totals - Orange County Business Journal

AEON Biopharma, Inc. (AEON) Stock Forecast & Price Prediction 2025–2030 - CoinCodex

AEON Biopharma (NASDAQ:AEON) Trading Up 5.9% – Time to Buy? - Defense World

AEON Biopharma (AEON) seeks shareholder approval for PIPE, note exchange and equity plan - Stock Titan

Will AEON Biopharma Inc. stock split attract more investorsMarket Sentiment Indicators & Calculate Profit Targets With AI Accuracy - bollywoodhelpline.com

Midday Stock Roundup: Shimmick Corp. climbs 14% - Orange County Business Journal

RPRX

$45.68

3.69%

MRNA

$53.83

6.87%

ROIV

$29.72

0.68%

BNTX

$101.95

1.78%

INSM

$143.57

4.21%

ONC

$292.94

2.03%

Yahooで開く | Google で開く | Finviz で開く | マーケットウォッチで開く | ロイターで開く